Tonix Pharmaceuticals Holding Corp. (TNXP)


Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Tonix Pharmaceuticals Holding Corp. chart...

About the Company

Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

98

Exchange

Nasdaq

$M

Total Revenue

98

Employees

$9M

Market Capitalization

-0.02

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TNXP News

Tonix Pharmaceuticals Holding (TNXP) Price Target Decreased by 37.78% to 3.57

6d ago, source: Fintel on MSN

The average one-year price target for Tonix Pharmaceuticals Holding (NasdaqCM:TNXP) has been revised to 3.57 / share. This is ...

Tonix Pharmaceuticals Holding Corp

1d ago, source: U.S. News & World Report

For most investors, the best investment strategy is to buy good stocks and hold them for the long run.

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

26d ago, source: Nasdaq

CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company ...

Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?

22d ago, source: Benzinga.com

Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million registered direct offering. Loading ...

Tonix Pharmaceuticals Holding Corp

21d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

26d ago, source: Stockhouse

CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company ...

Tonix Pharmaceuticals Holding Corp.

3d ago, source: Wall Street Journal

1 Day TNXP 1.91% DJIA 0.56% Russell 2K 0.24% Health Care/Life Sciences -0.67% ...

Tonix Pharmaceuticals Holding Corp. (TNXP)

5d ago, source: Yahoo Finance

Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth ...

Tonix Pharmaceuticals Holding Corp.

26d ago, source: Wall Street Journal

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...